Why the study?
Is the ACE I/D polymorphism associated with an increased risk of coronary artery disease in a Tunisian population?
Case-Control (n=445)
Is the ACE I/D polymorphism associated with an increased risk of coronary artery disease in a Tunisian population?
Answers are grounded in this paper and cite their sources.
The ACE D allele is associated with a significantly increased risk of coronary artery disease in a Tunisian population, a risk that is further potentiated by traditional cardiovascular risk factors.
BACKGROUND: Coronary artery disease (CAD), also known as atherosclerotic heart disease, is a leading cause of mortality and morbidity throughout the world. The role of insertion/deletion (I/D) polymorphisms of the angiotensin-converting enzyme (ACE) gene in the etiology of CAD remains to be more completely clarified. The aim of this study was to determine the role of the ACE I/D polymorphism in patients with CAD and to study the association together with traditional risk factors in assessing the risk of CAD. METHODS: Our study population included 145 Tunisian patients with symptomatic CAD and a control group of 300 people matched for age and sex. All participants in the study were genotyped for the ACE I/D polymorphisms obtained by polymerase chain reaction amplification on genomic DNA. RESULTS: ; OR = 6.8; 95% CI = 4.4-10) are significantly more prevalent among patients with CAD than in controls and may be predisposing to CAD. We further found that the risk of CAD is greatly potentiated by several concomitant risk factors (smoking, diabetes, hypertension, dyslipidemia, and a family history of CAD). CONCLUSION: The ACE D allele may be predictive in individuals who may be at risk of developing CAD. Further investigations of these polymorphisms and their possible synergisms with traditional risk factors for CAD could help to ascertain better predictability for CAD susceptibility.
No takes yet. Share an insight, caveat, or question.
Amara et al. (2016) conducted a case-control in Coronary artery disease (n=445). ACE I/D polymorphisms vs. Age- and sex-matched controls was evaluated on Coronary artery disease (OR 6.8, 95% CI 4.4-10).
Synapse has enriched 10 related papers. Consider them for comparative context: